Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Luc Descotes

Showing results (51-60 of 92) with videos related to

Pageof 10
Sort By:
Cell Death Discovery|February 27, 2026
Using 3D Invasion properties of RCC Cell Lines In Vitro to predict their Metastatic Potential In VivoBeatrice Cesana, Laurie Nemoz-Billet, Valentin Azemard, et al.
Cell Death & Disease|September 22, 2023
A new scaffold-free tumoroid model provides a robust preclinical tool to investigate invasion and drug response in Renal Cell CarcinomaIrinka Séraudie, Catherine Pillet, Beatrice Cesana, et al.
Cancers|January 23, 2020
Ex-Vivo Treatment of Tumor Tissue Slices as a Predictive Preclinical Method to Evaluate Targeted Therapies for Patients with Renal CarcinomaCaroline Roelants, Catherine Pillet, Quentin Franquet, et al.
The French Journal of Urology|October 10, 2025
Chemotherapy use in triplet approach for metastatic hormone-sensitive prostate cancer: French practice survey and expert opinionDelphine Borchiellini, Gwenaelle Gravis, Emmanuel Gross, et al.
Lasers in Surgery and Medicine|December 27, 2022
Intra-operative fluorescence-based detection of positive surgical margins during radical prostatectomy: Lessons learned from a pilot ex vivo translational studyGaelle Fiard, Cecilia Hughes, Redha Heus, et al.
European Urology Oncology|February 25, 2024
Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Biopsies for Prostate Cancer Diagnosis: Final Results of the Randomized PERFECT trial (CCAFU-PR1)Guillaume Ploussard, Eric Barret, Gaëlle Fiard, et al.
European Urology Focus|May 1, 2021
Superselective Ischemia in Robotic Partial Nephrectomy Does Not Provide Better Long-term Renal Function than Renal Artery Clamping in a Randomized Controlled Trial (EMERALD): Should We Take the Risk?Jean-Alexandre Long, Gaëlle Fiard, Joris Giai, et al.
World Journal of Urology|August 11, 2020
Timing and delay of radical prostatectomy do not lead to adverse oncologic outcomes: results from a large European cohort at the times of COVID-19 pandemicRomain Diamand, Guillaume Ploussard, Mathieu Roumiguié, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|March 22, 2007
[National prospective survey on the surgical quality of renal transplants in France. Study conducted by the Association Française d'Urologie Transplantation Committee]Grégory Verhoest, Laurent Salomon, Benoît Barrou, et al.
BJU International|June 24, 2009
Baseline renal function, ischaemia time and blood loss predict the rate of renal failure after partial nephrectomyClaudio Jeldres, Karim Bensalah, Umberto Capitanio, et al.
Pageof 10

Showing results (51-60 of 92) with videos related to

Sort By:
Pageof 10
Cell Death Discovery|February 27, 2026
Using 3D Invasion properties of RCC Cell Lines In Vitro to predict their Metastatic Potential In VivoBeatrice Cesana, Laurie Nemoz-Billet, Valentin Azemard, et al.
Cell Death & Disease|September 22, 2023
A new scaffold-free tumoroid model provides a robust preclinical tool to investigate invasion and drug response in Renal Cell CarcinomaIrinka Séraudie, Catherine Pillet, Beatrice Cesana, et al.
Cancers|January 23, 2020
Ex-Vivo Treatment of Tumor Tissue Slices as a Predictive Preclinical Method to Evaluate Targeted Therapies for Patients with Renal CarcinomaCaroline Roelants, Catherine Pillet, Quentin Franquet, et al.
The French Journal of Urology|October 10, 2025
Chemotherapy use in triplet approach for metastatic hormone-sensitive prostate cancer: French practice survey and expert opinionDelphine Borchiellini, Gwenaelle Gravis, Emmanuel Gross, et al.
Lasers in Surgery and Medicine|December 27, 2022
Intra-operative fluorescence-based detection of positive surgical margins during radical prostatectomy: Lessons learned from a pilot ex vivo translational studyGaelle Fiard, Cecilia Hughes, Redha Heus, et al.
European Urology Oncology|February 25, 2024
Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Biopsies for Prostate Cancer Diagnosis: Final Results of the Randomized PERFECT trial (CCAFU-PR1)Guillaume Ploussard, Eric Barret, Gaëlle Fiard, et al.
European Urology Focus|May 1, 2021
Superselective Ischemia in Robotic Partial Nephrectomy Does Not Provide Better Long-term Renal Function than Renal Artery Clamping in a Randomized Controlled Trial (EMERALD): Should We Take the Risk?Jean-Alexandre Long, Gaëlle Fiard, Joris Giai, et al.
World Journal of Urology|August 11, 2020
Timing and delay of radical prostatectomy do not lead to adverse oncologic outcomes: results from a large European cohort at the times of COVID-19 pandemicRomain Diamand, Guillaume Ploussard, Mathieu Roumiguié, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|March 22, 2007
[National prospective survey on the surgical quality of renal transplants in France. Study conducted by the Association Française d'Urologie Transplantation Committee]Grégory Verhoest, Laurent Salomon, Benoît Barrou, et al.
BJU International|June 24, 2009
Baseline renal function, ischaemia time and blood loss predict the rate of renal failure after partial nephrectomyClaudio Jeldres, Karim Bensalah, Umberto Capitanio, et al.
Pageof 10